| 16867-4 | Fibronectin aggregate IgG Ab | SERO |
| 16868-2 | Finch droppings IgE Ab (qualitative) | ALLERGY |
| 16869-0 | Flurbiprofen | DRUG/TOX |
| 1687-3 | 3-Methylhistidine (Urine) | CHEM |
| 16870-8 | Fluconazole (Urine) | DRUG/TOX |
| 16871-6 | Fluoride in Bone | DRUG/TOX |
| 16872-4 | Fluorocarbons | DRUG/TOX |
| 16873-2 | Follitropin --105 minutes post XXX challenge | CHAL |
| 16874-0 | Formate+Formaldehyde (Blood) | DRUG/TOX |
| 16875-7 | Francisella tularensis Ab | MICRO |
| 16876-5 | Francisella tularensis IgA Ab (qualitative, latex agglutination) | MICRO |
| 16877-3 | Francisella tularensis IgG Ab (qualitative, latex agglutination) | MICRO |
| 16878-1 | Francisella tularensis IgM Ab | MICRO |
| 16879-9 | Francisella tularensis Ag (qualitative, immunofluorescence) | MICRO |
| 1688-1 | 4-Pyridoxate | CHEM |
| 16881-5 | Gallium (Blood) | DRUG/TOX |
| 16882-3 | Gamma aminobutyrate (Urine, qualitative) | CHEM |
| 16883-1 | Gamma aminobutyrate (Urine) | CHEM |
| 16884-9 | Gamma aminobutyrate (qualitative) | CHEM |
| 16885-6 | Gamma aminobutyrate | CHEM |
| 16886-4 | Gamma aminobutyrate (CSF) | CHEM |
| 16887-2 | Gamma aminobutyrate (Amniotic Fluid) | CHEM |
| 16888-0 | Gamma chlordane (Urine) | DRUG/TOX |
| 1689-9 | 5'-Nucleotidase (Amniotic Fluid) | CHEM |
| 16890-6 | Gastrin --10 minutes post XXX challenge | CHAL |
| 16891-4 | Gastrin --11th specimen post XXX challenge | CHAL |
| 16892-2 | Gastrin --15 minutes post XXX challenge | CHAL |
| 16893-0 | Gastrin --20 minutes post XXX challenge | CHAL |
| 16894-8 | Gastrin --25 minutes post XXX challenge | CHAL |
| 16895-5 | Gastrin --30 minutes post XXX challenge | CHAL |
| 16896-3 | Gastrin --5 minutes post XXX challenge | CHAL |
| 16898-9 | Giardia lamblia 65 Ag (Stool, qualitative) | MICRO |
| 16899-7 | Giardia lamblia Ag in Specimen (qualitative) | MICRO |
| 169-3 | Cephradine (minimum inhibitory concentration (mic)) | ABXBACT |
| 1690-7 | 5'-Nucleotidase | CHEM |
| 16900-3 | Gliadin Ab (oral fluid) (Saliva) | SERO |
| 16901-1 | Gliadin IgA Ab (qualitative) | SERO |
| 16902-9 | Gliadin IgG Ab (qualitative) | SERO |
| 16903-7 | Glucose in Vitreous fluid | CHEM |
| 16904-5 | Glucose --1st specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16905-2 | Glucose --2nd specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16906-0 | Glucose --3rd specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16907-8 | Glucose --4th specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16908-6 | Glucose --5th specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16909-4 | Glucose --6th specimen post XXX challenge (Urine, qualitative) | CHAL |
| 1691-5 | 5,10-Methylenetetrahydrofolate reductase | CHEM |
| 16910-2 | Glucose --7th specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16911-0 | Glucose --8th specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16912-8 | Glucose --9th specimen post XXX challenge (Urine, qualitative) | CHAL |
| 16913-6 | Fasting glucose (Urine, qualitative) | CHAL |